AnaWl_dia Lima, Zulma Medeiros, ZaildeCarvalhoDos Santos, GertrudesMonteiroda Costa, Cynthia Braga
Index: Rev. Soc. Bras. Med. Trop. 45(6) , 745-50, (2012)
Full Text: HTML
The Global Programme to Eliminate Lymphatic Filariasis was launched with the goal of eliminating this disease via the annual mass drug administration (MDA) of a single dose of antifilarial drugs. Adverse drug reactions following MDA are a major factor of poor treatment adherence in several countries. This study assessed the occurrence of adverse drug reactions (ADRs) following the first round of mass treatment in two communities treated with different dosages of diethylcarbamazine (DEC) in the City of Recife, Brazil.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Diethylcarbamazine Citrate
CAS:1642-54-2 |
C16H29N3O8 |
|
Liquid chromatography-mass spectrometry analysis of diethylc...
2014-09-01 [J. Pharm. Biomed. Anal. 98 , 307-10, (2014)] |
|
Immunomodulatory effect of diethylcarbamazine in mice infect...
2014-11-01 [Int. Immunopharmacol. 23(1) , 113-20, (2015)] |
|
Loa loa—does it deserve to be neglected?
2014-04-01 [Lancet Infect. Dis. 14(4) , 353-7, (2014)] |
|
In vitro and in vivo antifilarial activity evaluation of 3,6...
2012-02-15 [Bioorg. Med. Chem. Lett. 22 , 1527-32, (2012)] |
|
Role of leukotrienes in N-(3,5-dichlorophenyl)succinimide (N...
2012-10-09 [Toxicology 300(1-2) , 92-9, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
